Kintegral Advisory LLC Has $4.16 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Kintegral Advisory LLC cut its position in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 4.4% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 8,224 shares of the healthcare conglomerate’s stock after selling 383 shares during the quarter. Kintegral Advisory LLC’s holdings in UnitedHealth Group were worth $4,160,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of UNH. AMF Tjanstepension AB grew its position in shares of UnitedHealth Group by 88.0% during the 3rd quarter. AMF Tjanstepension AB now owns 258,833 shares of the healthcare conglomerate’s stock worth $151,374,000 after buying an additional 121,180 shares during the period. Hudson Value Partners LLC grew its holdings in UnitedHealth Group by 8.3% in the third quarter. Hudson Value Partners LLC now owns 1,069 shares of the healthcare conglomerate’s stock worth $625,000 after purchasing an additional 82 shares during the period. Wealth Group Ltd. boosted its position in shares of UnitedHealth Group by 4.0% during the 3rd quarter. Wealth Group Ltd. now owns 1,777 shares of the healthcare conglomerate’s stock worth $1,039,000 after purchasing an additional 68 shares in the last quarter. Howard Capital Management Group LLC bought a new stake in UnitedHealth Group in the 3rd quarter valued at about $341,000. Finally, McAdam LLC boosted its holdings in UnitedHealth Group by 25.5% in the third quarter. McAdam LLC now owns 759 shares of the healthcare conglomerate’s stock worth $444,000 after acquiring an additional 154 shares in the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Insider Activity

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction dated Friday, January 17th. The stock was bought at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now owns 4,500 shares in the company, valued at $2,302,065. This trade represents a 28.57 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Insiders own 0.33% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities analysts have recently weighed in on UNH shares. Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Oppenheimer raised their price objective on shares of UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a research note on Friday, December 6th. Stephens upped their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a report on Thursday, December 5th. Cantor Fitzgerald reissued an “overweight” rating and set a $700.00 price objective on shares of UnitedHealth Group in a report on Friday, January 17th. Finally, HSBC raised UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. One investment analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company has an average rating of “Buy” and an average price target of $629.32.

UnitedHealth Group Stock Down 7.3 %

UnitedHealth Group stock opened at $465.58 on Friday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The firm has a 50 day moving average price of $519.27 and a 200-day moving average price of $560.54. The company has a market capitalization of $428.46 billion, a P/E ratio of 30.04, a P/E/G ratio of 1.37 and a beta of 0.61.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion for the quarter, compared to analysts’ expectations of $101.60 billion. During the same quarter in the prior year, the firm earned $5.83 EPS. The business’s revenue for the quarter was up 6.8% compared to the same quarter last year. As a group, equities analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.